StockData
Haemonetics Corp logo

Haemonetics Corp (HAE) stock

HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q1 FY2027, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3077% above fair value
$122.86+1.94 (+1.60%)

Close on Nov 18, 2026Market cap $5.59BP/E 59.9Yield –

Haemonetics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Haemonetics's free cash flow for the twelve months ending Jun 27, 2026 was $291.22M, up 53.9% year over year. For fiscal 2026 it was $260.44M, up 82.8% from the year before. Over ten years it grew 29.6% a year on average. The highest annual figure on record is $260.44M in fiscal 2026.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Mar 28, 2026$260.44M+82.8%
FY2025Mar 29, 2025$142.45M-0.8%
FY2024Mar 30, 2024$143.63M+75.7%
FY2023Apr 1, 2023$81.73M+7.9%
FY2022Apr 2, 2022$75.75M+5.6%
FY2021Apr 3, 2021$71.77M-34.4%
FY2020Mar 28, 2020$109.46M+171.5%
FY2019Mar 30, 2019$40.32M-72.3%
FY2018Mar 31, 2018$145.55M+74.1%
FY2017Apr 1, 2017$83.60M+329.6%
FY2016Apr 2, 2016$19.46M+292.5%
FY2015Mar 28, 2015$4.96M-92.5%
FY2014Mar 29, 2014$65.88M+187.8%
FY2013Mar 30, 2013$22.89M-63.2%
FY2012Mar 31, 2012$62.12M-19.1%
FY2011Apr 2, 2011$76.79M+3.3%
FY2010Apr 3, 2010$74.36M+24.0%
FY2009Mar 28, 2009$59.99M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 27, 2026$44.42M+225.6%
Q4 FY2026CQ1 2026Mar 28, 2026$53.28M-47.2%
Q3 FY2026CQ4 2025Dec 27, 2025$87.22M+147.6%
Q2 FY2026CQ3 2025Sep 27, 2025$106.31M+169.9%
Q1 FY2026CQ2 2025Jun 28, 2025$13.64M–
Q4 FY2025CQ1 2025Mar 29, 2025$100.91M+75.8%
Q3 FY2025CQ4 2024Dec 28, 2024$35.22M–
Q2 FY2025CQ3 2024Sep 28, 2024$39.39M-56.2%
Q1 FY2025CQ2 2024Jun 29, 2024-$33.08M-390.0%
Q4 FY2024CQ1 2024Mar 30, 2024$57.40M–
Q3 FY2024CQ4 2023Dec 30, 2023-$15.19M-131.9%
Q2 FY2024CQ3 2023Sep 30, 2023$90.01M+76.2%
Q1 FY2024CQ2 2023Jul 1, 2023$11.41M–
Q4 FY2023CQ1 2023Apr 1, 2023-$13.44M-140.8%
Q3 FY2023CQ4 2022Dec 31, 2022$47.57M+33.0%
Q2 FY2023CQ3 2022Oct 1, 2022$51.08M+125.5%
Q1 FY2023CQ2 2022Jul 2, 2022-$3.47M–
Q4 FY2022CQ1 2022Apr 2, 2022$32.94M–
Q3 FY2022CQ4 2021Jan 1, 2022$35.77M-37.2%
Q2 FY2022CQ3 2021Oct 2, 2021$22.65M+8.8%
Q1 FY2022CQ2 2021Jul 3, 2021-$15.60M-479.0%
Q4 FY2021CQ1 2021Apr 3, 2021-$10.09M-128.2%
Q3 FY2021CQ4 2020Dec 26, 2020$56.92M-3.4%
Q2 FY2021CQ3 2020Sep 26, 2020$20.82M+1.9%
Q1 FY2021CQ2 2020Jun 27, 2020$4.12M–
Q4 FY2020CQ1 2020Mar 28, 2020$35.76M+416.6%
Q3 FY2020CQ4 2019Dec 28, 2019$58.89M+103.6%
Q2 FY2020CQ3 2019Sep 28, 2019$20.43M+130.3%
Q1 FY2020CQ2 2019Jun 29, 2019-$5.62M–
Q4 FY2019CQ1 2019Mar 30, 2019$6.92M-82.0%
Q3 FY2019CQ4 2018Dec 29, 2018$28.92M-25.5%
Q2 FY2019CQ3 2018Sep 29, 2018$8.87M-79.6%
Q1 FY2019CQ2 2018Jun 30, 2018-$4.39M-117.8%
Q4 FY2018CQ1 2018Mar 31, 2018$38.52M+103.2%
Q3 FY2018CQ4 2017Dec 30, 2017$38.82M+6.9%
Q2 FY2018CQ3 2017Sep 30, 2017$43.50M+116.2%
Q1 FY2018CQ2 2017Jul 1, 2017$24.70M–
Q4 FY2017CQ1 2017Apr 1, 2017$18.96M–
Q3 FY2017CQ4 2016Dec 31, 2016$36.31M–
Q2 FY2017CQ3 2016Oct 1, 2016$20.12M–

More Haemonetics figures

See a number that looks wrong?